Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 16 to 30 of 160 results for copd

  1. myAIRVO2 for the treatment of chronic obstructive pulmonary disease (MIB161)

    NICE has developed a medtech innovation briefing (MIB) on myAIRVO2 for the treatment of chronic obstructive pulmonary disease .

    Medtech innovation briefing
    Published
    1 October 2018

  2. FreeO2 automatic oxygen titration for chronic obstructive pulmonary disease and respiratory distress syndrome (MIB281)

    NICE has developed a medtech innovation briefing (MIB) on FreeO2 automatic oxygen titration for chronic obstructive pulmonary disease and respiratory distress syndrome .

    Medtech innovation briefing
    Published
    7 December 2021

  3. Endobronchial nerve ablation for chronic obstructive pulmonary disease (IPG714)

    Evidence-based recommendations endobronchial nerve ablation for chronic obstructive pulmonary disease. This involves destroying (ablating) the nerves on the outside of the airway (endobronchial nerves) to improve breathing.

    Interventional procedures guidance
    Published
    15 December 2021
    View recommendations

    Sections for IPG714

  4. The proportion of people with COPD and MRC dyspnoea scale 3 and above referred to a pulmonary rehabilitation programme

    The proportion of people with COPD and MRC dyspnoea scale 3 and above referred to a pulmonary rehabilitation programme Subject(s):

    Clinical Commissioning Group indicator
    Published
    3 November 2020

  5. The percentage of patients with COPD who have had influenza immunisation in the preceding 1 August to 31 March

    The percentage of patients with COPD who have had influenza immunisation in the preceding 1 August to 31 March Subject(s): Respiratory

    General practice indicator suitable for use in the QOF
    Published
    4 November 2020

  6. NICE impact respiratory conditions

    Find out about the progress made by the health and care system in implementing NICE guidance on respiratory conditions

  7. The percentage of patients with COPD and Medical Research Council (MRC) Dyspnoea Scale of 3 or more at any time in the preceding 15 months, with a subsequent record of an offer of referral to a pulmonary rehabilitation programme

    NICE indicators. NM47 COPD guidance.

    General practice indicator suitable for use in the QOF
    Published
    3 November 2020

  8. The percentage of patients with very severe chronic obstructive pulmonary disease (COPD) with a record of oxygen saturation value within the preceding 12 months

    The percentage of patients with very severe chronic obstructive pulmonary disease (COPD) with a record of oxygen saturation...

    General practice indicator suitable for use in the QOF
    Published
    25 September 2023

  9. Virtual Wards for COPD exacerbations

    Awaiting development [GID-MT608] Expected publication date: TBC

    Medical technologies guidance
    Awaiting development

  10. The contractor establishes and maintains a register of: 1. Patients with a clinical diagnosis of COPD before (start date), and 2. Patients with a clinical diagnosis of COPD on or after (start date) whose diagnosis has been confirmed by a quality assured post bronchodilator spirometry FEV1/FVC ratio below 0.7 between 3 months before or 3 months after diagnosis.

    NM169

    General practice indicator suitable for use in the QOF
    Published
    19 March 2020

  11. Inhaled therapies for people with COPD and asthma- What is the clinical and cost effectiveness of inhaled therapies (bronchodilators and/or inhaled corticosteroids) in people with both stable COPD and asthma?

    Recommendation ID NG115/3 Question Inhaled therapies for people with COPD and asthma- What is the clinical and cost effectiveness of...

    Research recommendation
    Published
    6 February 2019

  12. Diagnosing COPD: -  What are the characteristics of people diagnosed with COPD as a result of an incidental finding ofemphysema on a CT scan, compared with those diagnosed with symptoms?

    NG115/6 Question Diagnosing COPD: - What are the characteristics of people diagnosed with COPD as a result of an...

    Research recommendation
    Published
    13 February 2019

  13. Chronic obstructive pulmonary disease

    All NICE products on chronic obstructive pulmonary disease. Includes any guidance, advice and quality standards.

    Topic page

  14. O2matic PRO 100 for optimising oxygen treatment in respiratory conditions (MIB308)

    NICE has developed a medtech innovation briefing (MIB) on O2matic PRO 100 for optimising oxygen treatment in respiratory conditions .

    Medtech innovation briefing
    Published
    11 October 2022

  15. The percentage of patients with any or any combination of the following conditions: CHD, PAD, stroke or TIA, hypertension, diabetes, COPD, CKD or asthma, whose notes record smoking status in the preceding 12 months

    the following conditions: CHD, PAD, stroke or TIA, hypertension, diabetes, COPD, CKD or asthma, whose notes record smoking status in the...

    General practice indicator suitable for use in the QOF
    Published
    3 March 2021